FDA approves mini CPAP device for travelers

The Food and Drug Administration granted market clearance for ResMed's AirMini device.

The AirMini is a small, portable continuous positive airway pressure device for patients with sleep apnea.

The device is intended for use as a secondary CPAP for individuals to maintain sleep apnea therapy while traveling, according to a news release.

San Diego-based ResMed expects to launch the device later this year.

More articles on supply chain:

6 noteworthy drugs the FDA approved in 2016
HHS Sec. Burwell's advice to Dr. Tom Price: Prioritize cybersecurity
Valeant to sell off $2B in assets to ease debt: 3 takeaways

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Whitepapers

Featured Webinars